No Data
No Data
Express News | CG Oncology Shares Are Trading Higher After the Company Announced That Cretostimogene Grenadenorepvec Monotherapy Data Was Presented at the American Urological Association Annual Meeting
Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings
CG Oncology Shares Climb on Bladder-Cancer Treatment Results
12 Health Care Stocks Moving In Monday's Pre-Market Session
CG Oncology Announces Promising Phase 3 Trial Results
TD Cowen Sticks to Its Buy Rating for CG Oncology, Inc. (CGON)